TipRanks Capital return
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1–36
- Matches
- 1204
- Sources here
- 14
- Companies here
- 17
Active search
1204 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
AMD (AMD) Stock Trades Up, Here Is Why
AMD (AMD) Stock Trades Up, Here Is Why What Happened? Shares of computer processor maker AMD (NASDAQ:AMD) jumped 5.1% in the afternoon session after the company priced a $4.75 billion bond offering to fund its expansion into the artificial intelligence and data center markets, …
AMD Stock And 2 AI Infrastructure Names for Lower Rate Growth
This article examines three interest-rate-sensitive growth stocks – Monolithic Power Systems (MPWR), Arista Networks (ANET), and Advanced Micro Devices (AMD) – that are poised to benefit from softer U.S. inflation readings and potential peak interest rates. It details each company's operations, market position in …
Advanced Micro Devices, Inc. $AMD Shares Bought by TCW Group Inc.
TCW Group Inc. significantly increased its stake in Advanced Micro Devices (NASDAQ:AMD) during the second quarter, purchasing an additional 12,294 shares and raising its total holdings to 39,918 shares valued at $23.19 million. Several other institutional investors also adjusted their positions in AMD, with …
Solstice Advanced Materials, Inc. (SOLS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Solstice Advanced Materials, Inc. (NASDAQ: SOLS) following a significant stock price drop after its announcement to acquire Element Solutions for $14.5 billion. Despite the CEO's positive outlook on the acquisition, …
TripAdvisor Down Over 23%, On Pace for Largest Percent Decrease Since May 2024 -- Data Talk
TripAdvisor's stock is experiencing a significant downturn, dropping over 23% and heading for its largest single-day percentage decrease since May 2024. This notable decline is impacting the company's market performance.
BofA Securities Maintains Aardvark Therapeutics(AARD.US) With Sell Rating
BofA Securities has reiterated its Sell rating on Aardvark Therapeutics (AARD.US). The article does not provide further details regarding the financial implications or the analyst's rationale for maintaining this rating.
Precision Trading with Doubleverify Holdings Inc. (DV) Risk Zones
This article from Stock Traders Daily provides a detailed analysis of Doubleverify Holdings Inc. (DV) using AI-generated trading strategies. It highlights strong near and mid-term sentiment, a weak long-term outlook, and outlines specific position, momentum breakout, and risk hedging strategies with entry, target, and …
AMD, Intel and NVIDIA All Rally as Super Micro’s Blowout Numbers Reignite the AI Trade
Three of the biggest names in logic chips closed higher on August 12, following a strong earnings report deep in the AI server supply chain. Advanced Micro Devices, Inc. (NASDAQ:AMD) up 1.8% at $483, Intel Corporation (NASDAQ:INTC) up 3.3% to $101, and NVIDIA Corporation …
Assenagon Asset Management S.A. Has $1.07 Million Stock Holdings in Rayonier Advanced Materials Inc. $RYAM
Assenagon Asset Management S.A. significantly reduced its stake in Rayonier Advanced Materials Inc. (NYSE:RYAM) by 67.7% in the second quarter, now holding 136,437 shares valued at $1.07 million. Despite this, other institutional investors have recently acquired new positions or increased their holdings in the …
Solstice Advanced Mat (NASDAQ:SOLS) Upgraded at Wall Street Zen
Wall Street Zen has upgraded Solstice Advanced Mat (NASDAQ:SOLS) from a "hold" to a "buy" rating. Analysts collectively give SOLS a "Moderate Buy" consensus rating with an average price target of $78.25, while the company recently exceeded earnings expectations, reporting $0.88 EPS against a …
Aardvark Therapeutics (NASDAQ:AARD) Raised to "Sell" at Wall Street Zen
Wall Street Zen upgraded Aardvark Therapeutics (NASDAQ:AARD) from "strong sell" to "sell," while the broader analyst consensus on MarketBeat remains a "hold" with a $16.30 price target. The clinical-stage biopharmaceutical company, specializing in treatments for autoimmune and inflammatory diseases, reported a quarterly loss of …
Stockholder Alert: Robbins LLP Informs Investors of the Aardvark Therapeutics, Inc. (UWM) Class Action
Robbins LLP has filed a class action lawsuit against Aardvark Therapeutics, Inc. (NASDAQ: AARD) on behalf of investors who purchased shares during its February 13, 2025 IPO or between February 13, 2025 and May 14, 2026. The lawsuit alleges that Aardvark misled investors regarding …
CastleKnight group discloses 5.9% ADV stake in Schedule 13G/A filing
CastleKnight Master Fund LP and related entities have filed an amended Schedule 13G/A, disclosing a 5.9% beneficial ownership stake in Advantage Solutions Inc. (ADV). As of August 14, 2026, the group beneficially owned 757,354 shares of Class A common stock, an increase from 581,347 …